VEEV icon

Veeva Systems

233.69 USD
+2.05
0.88%
At close Apr 30, 4:00 PM EDT
After hours
233.69
+0.00
0.00%
1 day
0.88%
5 days
5.21%
1 month
0.89%
3 months
-1.43%
6 months
8.82%
Year to date
10.97%
1 year
17.69%
5 years
22.48%
10 years
780.19%
 

About: Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Employees: 7,291

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

65% more first-time investments, than exits

New positions opened: 134 | Existing positions closed: 81

24% more call options, than puts

Call options by funds: $358M | Put options by funds: $289M

4% more funds holding

Funds holding: 939 [Q3] → 974 (+35) [Q4]

2.16% more ownership

Funds ownership: 77.57% [Q3] → 79.73% (+2.16%) [Q4]

7% more repeat investments, than reductions

Existing positions increased: 352 | Existing positions reduced: 330

3% more capital invested

Capital invested by funds: $26.4B [Q3] → $27.2B (+$876M) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 16 [Q3] → 16 (+0) [Q4]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$201
14%
downside
Avg. target
$250
7%
upside
High target
$285
22%
upside

9 analyst ratings

positive
56%
neutral
33%
negative
11%
Piper Sandler
Brent Bracelin
41% 1-year accuracy
51 / 125 met price target
9%upside
$255
Overweight
Maintained
23 Apr 2025
Keybanc
Sangita Jain
36% 1-year accuracy
17 / 47 met price target
7%upside
$250
Overweight
Maintained
16 Apr 2025
JP Morgan
Anne Samuel
50% 1-year accuracy
17 / 34 met price target
7%upside
$249
Neutral
Maintained
20 Mar 2025
Scotiabank
Allan Verkhovski
36% 1-year accuracy
5 / 14 met price target
5%upside
$245
Sector Perform
Maintained
6 Mar 2025
Truist Securities
Joe Meares
0 / 0 met price target
7%downside
$217
Hold
Maintained
6 Mar 2025

Financial journalist opinion

Based on 22 articles about VEEV published over the past 30 days

Positive
Zacks Investment Research
11 hours ago
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Neutral
PRNewsWire
1 day ago
Announcing Veeva AI
Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial PLEASANTON, Calif. , April 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts.
Announcing Veeva AI
Neutral
Zacks Investment Research
5 days ago
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Veeva Systems (VEEV) closed the most recent trading day at $227.11, moving -0.26% from the previous trading session.
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Positive
Zacks Investment Research
6 days ago
Here's Why You Should Add Veeva Stock to Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
Here's Why You Should Add Veeva Stock to Your Portfolio Now
Positive
Zacks Investment Research
1 week ago
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era
Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era
Neutral
Zacks Investment Research
1 week ago
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
Negative
The Motley Fool
1 week ago
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days.
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Positive
Zacks Investment Research
1 week ago
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
Neutral
Business Wire
2 weeks ago
Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research
NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program. This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and.
Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research
Neutral
Zacks Investment Research
2 weeks ago
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV) closed the most recent trading day at $222.72, moving -0.42% from the previous trading session.
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Charts implemented using Lightweight Charts™